This chapter describes the current cross-strait patent laws in Mainland China and Taiwan, and explores whether gene sequencing and its related technologies are patentable, and if so, whether there are further restrictions. The legal system for the cross-strait development of gene patentability and...

This chapter discusses the history of intellectual property rights (IPR) and the forms of IPR in biotechnology. It defines patents and enumerates the prerequisites for patents, the non-patentable and patentable inventions in India, and the sources of patent information such as databases and patent...

This chapter highlights patent issues over drug research innovation related to technological regulations, public health and harnessing the health benefits of natural compounds for drug development, with special context to India. The biotechnology patent scenario and the synthetic drugs and natural...

This chapter defines biosimilars/biogenerics and discusses the importance of biotherapeutics in healthcare. The intellectual property rights issues, the resolution of patent disputes, new intellectual property challenges, regulatory issues and guidelines are discussed. The nomenclature of...

This chapter examines innovations in human and veterinary vaccines against infections and intellectual property rights (IPR) issues in biotechnology from the Brazilian perspective. From this perspective, it proposes a comprehensive approach to vaccine innovation in the developing world, examining...

In the recent WARF (Wisconsin Alumni Research Foundation) case, patents related to embryonic stem cells (ESCs) were granted by the US Patent and Trademark Office (USPTO) based on technical grounds, whereas the European Patent Office (EPO) rejected to grant any patents involving the destruction of...

This chapter discusses public interest and the patent system in healthcare innovations. The association between patents and commercial biomedicine, the actual claims of drug companies and what the patent law permits, and the patenting of enantiomers and other variants are described.

This chapter looks at the progress achieved by agricultural biotechnology companies in India in the field of commercialization of biotechnological services and products. The particular focal point of this chapter is on intellectual property rights (IPR) related to plant biotechnology. It is...

This chapter focuses on Canada's novel approach to GM regulations. It discusses the recently adopted Agricultural Growth Act (AGA) which amends several key aspects of the Seeds Act and the Plant Breeders' Rights Act. The implications of AGA for intellectual property rights (IPRs), seed ownership...

This chapter focuses on the contemporary system of agricultural biotechnology innovation, which consists of a balance of exclusive and non-exclusive access to proprietary technologies to effectively support new crop development and the provision of both commercial growers and subsistence farmers...